Hepatitis A and E seroprevalence and associated risk factors: A community-based cross-sectional survey in rural Amazonia

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Vitral, Claudia L ^a,b   da Silva Nunes, Mônica ^c   Pinto, Marcelo A ^b   de Oliveira, Jaqueline M ^b   Gaspar, Ana Maria C ^b   Pereira, Rebeca Cristina C ^a   Ferreira, Marcelo U ^c  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amazon basin; Hepatitis A; Hepatitis E; Seroprevalence

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; BRAZIL; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS A; HEPATITIS E; HUMAN; IMMUNOBLOTTING; INFECTION RATE; INFECTION RISK; MALE; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SCHOOL CHILD; SEROPREVALENCE; VERY ELDERLY; ADULT; BLOOD; EPIDEMIOLOGY; HEPATITIS A VIRUS; HEPATITIS E VIRUS; MIDDLE AGED; RISK; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84906825501     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-458     Document Type: Article

References (63)

1. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008, 48(3):494-503.
2. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, Yarasheva DM, Bradley DW, Margolis HS. Serological identification of hepatitis E virus infections in epidemic and endemic setting. J Med Virol 1992, 36(4):246-250.
3. Jacobsen KH, Wiersma ST. Hepatitis a virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010, 28(41):6653-6657.
4. Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis E virus: the current scenario. Int J Infect Dis 2013, 17(4):228-233.
5. Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol 2010, 140(3-4):256-265.
6. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8(11):698-709.
7. Dalton HR, Fellows HJ, Gane EJ, Wong P, Gerred S, Schroeder B, Croxson MC, Garkavenko O. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007, 22(8):1236-1240.
8. Lopes Dos Santos DR, Lewis-Ximenez LL, da Silva MF, de Sousa PS, Gaspar AM, Pinto MA. First report of a human autochthonous hepatitis E virus infection in Brazil. J Clin Virol 2010, 47(3):276-279.
9. Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, Vischi F, Alric L, Vinel JP, Izopet J. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004, 74(3):419-424.
10. Tsang TH, Denison EK, Williams HV, Venczel LV, Ginsberg MM, Vugia DJ. Acute hepatitis E infection acquired in California. Clin Infect Dis 2000, 30(3):618-619.
11. Ciaccia MC, Moreira RC, Ferraro AA, Lemos MF, Oba IT, Porta G. Epidemiological and serological aspects of hepatitis a among children and teenagers in the city of Santos: a cross-sectional study. Sao Paulo Med J 2012, 130(4):230-235.
12. Gonc¸alves AA, Oliveira LC. Seroprevalence of hepatitis a immunity among children and adolescents in two cities of the triaˆngulo mineiro region, state of Minas Gerais, Brazil. Braz J Infect Dis 2012, 16(5):496-497.
13. Krebs LS, Ranieri TM, Kieling CO, Ferreira CT, da Silveira TR. Shifting susceptibility to hepatitis a among children and adolescents over the past decade. J Pediatria 2011, 87(3):213-214.
14. Markus JR, Cruz CR, Maluf EMCP, Tahan TT, Hoffman MM. Seroprevalence of hepatitis a in children and adolescents. J Pediatria 2011, 87(5):419-424.
15. Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002-a review. Mem Inst Oswaldo Cruz 2006, 101(2):119-127.
16. Vitral CL, Ospina FL, Artimos S, Melgac¸o JG, Cruz OG, de Paula VS, Luz SB, Freire M, Gaspar LP, Amado LA, Engstrom EM, Fortes CD, Souza TC, Dias MN, Gaspar AM, Souto FJ. Declining prevalence of hepatitis a virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis a vaccination in brazil. Mem Inst Oswaldo Cruz 2012, 107(5):652-658.
17. Vitral CL, Souto FJ, Gaspar AM. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy. J Viral Hepat 2008, 15(Suppl 2):22-25.
18. Vitral CL, Yoshida CF, Lemos ER, Teixeira CS, Gaspar AM. Age-specific prevalence of antibodies to hepatitis a in children and adolescents from Rio de Janeiro, brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Mem Inst Oswaldo Cruz 1998, 93(1):1-5.
19. de Alencar Ximenes RA, Martelli CM, Mercha´n-Hamann E, Montarroyos UR, Braga MC, de Lima ML, Cardoso MR, Turchi MD, Costa MA, de Alencar LC, Moreira RC, Figueiredo GM, Pereira LM, Group HS. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-West regions of Brazil. Int J Epidemiol 2008, 37(4):852-861.
20. Sartori AM, de Soa´rez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine 2012, 30(52):7489-7497.
21. Bensabath G, Hadler SC, Soares MC, Fields H, Maynard JE. Epidemiologic and serologic studies of acute viral hepatitis in Brazil's Amazon Basin. Bull Pan Am Health Organ 1987, 21(1):16-27.
22. Braga WS, Borges FG, Barros Ju´nior GM, Martinho AC, Rodrigues IS, Azevedo EP, Davis GH, Queiroz MB, Santos SH, Barbosa TV, Castilho MC. Prevalence of hepatitis A virus infection: the paradoxical example of isolated communities in the western Brazilian Amazon region. Rev Soc Bras Med Trop 2009, 42(3):277-281.
23. de Paula VS, Arruda ME, Vitral CL, Gaspar AM. Seroprevalence of viral hepatitis in riverine communities from the Western Region of the Brazilian Amazon Basin. Mem Inst Oswaldo Cruz 2001, 96(8):1123-1128.
24. Gayotto LC, Quarentei AA, Cabral GI. Soroepidemiologia das hepatites A e B nas regiões dos rios Bia´ e Alto Jurua´, Amazoˆnia Ocidental. GED Gastroenterol Endosc Dig 1984, 3:106-112.
25. Carrilho FJ, Mendes Clemente C, Silva LC. Epidemiology of hepatitis A and E virus infection in Brazil. Gastroenterol Hepatol 2005, 28(3):118-125.
26. de Carvalho LG, Marchevsky RS, dos Santos DR, de Oliveira JM, de Paula VS, Lopes LM, Van der Poel WH, Gonza´lez JE, Munne´ MS, Moran J, Cajaraville AC, Pelajo-Machado M, Cruz OG, Pinto MA. Infection by Brazilian and Dutch swine hepatitis E virus strains induces haematological changes in Macaca fascicularis. BMC Infect Dis 2013, 23(13):495-506.
27. Echevarri´a JM, Gonza´lez JE, Lewis-Ximenez LL, Dos Santos DR, Munne´ MS, Pinto MA, Pujol FH, Rodri´guez-Lay LA. Hepatitis E virus infection in Latin America: a review. J Med Virol 2013, 85(6):1037-1045.
28. Assis SB, Souto FJ, Fontes CJ, Gaspar AM. Prevalence of hepatitis A and E virus infection in school children of an Amazonian municipality in Mato Grosso State. Rev Soc Bras Med Trop 2002, 35(2):155-158.
29. Pang L, Alencar FE, Cerutti C, Milhous WK, Andrade AL, Oliveira R, Kanesa-Thasan N, MaCarthy PO, Hoke CH. Short report: hepatitis E infection in the Brazilian Amazon. Am J Trop Med Hyg 1995, 52(4):347-348.
30. Souto FJ, Fontes CJ. Prevalence of IgG-class antibodies against hepatitis E virus in a community of the southern Amazon: a randomized survey. Ann Trop Med Parasitol 1998, 92(5):623-625.
31. de Souza EA, da Silva-Nunes M, Malafronte RS, Muniz PT, Cardoso MA, Ferreira MU. Prevalence and spatial distribution of intestinal parasitic infections in a rural Amazonian settlement, Acre State, Brazil. Cad Saude Publica 2007, 23(2):427-434.
32. da Silva-Nunes M, Codec¸o CT, Malafronte RS, da Silva NS, Juncansen C, Muniz PT, Ferreira. Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control. Am J Trop Med Hyg 2008, 79(4):624-635.
33. Santos DC, Souto FJ, Santos DR, Vitral CL, Gaspar AM. Seroepidemiological markers of enterically transmitted viral hepatitis A and E in individuals living in a community located in the North Area of Rio de Janeiro, RJ, Brazil. Mem Inst Oswaldo Cruz 2002, 97(5):637-640.
34. Almeida D, Tavares-neto J, Vitvitski L, Almeida A, Mello C, Santana D, Tatsch F, Parana´ R. Serological markers of hepatitis A, B and C viruses in rural communities of the semiarid Brazilian northeast. Braz J Infect Dis 2006, 10:317-321.
35. Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banque´-Navarro M, Da´valos-Gamboa MR, Montaño-Rodri´guez SL. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study. J Med Virol 2013, 85:1692-1697.
36. Trinta KS, Liberto MI, de Paula VS, Yoshida CF, Gaspar AM. Hepatitis E virus infection in selected Brazilian populations. Mem Inst Oswaldo Cruz 2001, 96(1):25-29.
37. Bortoliero AL, Bonametti AM, Morimoto HK, Matsuo T, Reiche EM. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Parana´, Brazil. Rev Inst Med Trop Sao Paulo 2006, 48(2):87-92.
38. Silva SM, Oliveira JM, Vitral CL, Vieira Kde A, Pinto MA, Souto FJ. Prevalence of hepatitis E virus antibodies in individuals exposed to swine in MatoGrosso, Brazil. Mem Inst Oswaldo Cruz 2012, 107(3):338-341.
39. Karentnyi YV, Favorov MO, Khudyakova NS, Weiss P, Bar-Shani S, Handsher R, Aboudy Y, Varsano N, Schwartz E, Levin E. Serological evidence for hepatitis E virus infection in Israel. J Med Virol 1995, 45(3):316-320.
40. Echevarri´a JM, . Light and Darkness Prevalence of Hepatitis E Virus Infection among the General Population. Scientifica 2014, 2014:1-14. Light and Darkness.
41. Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res 2011, 161:84-92.
42. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012, 367(13):1237-1244.
43. Bendall R, Ellis V, Ijaz S, Ali R, Dalton HR. A comparison of two commercially available anti-HEV IgG kits and a re-avaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
44. Ma H, Song X, Li Z, Harrison TJ, Zhang H, Huang W, Hao W, Kong W, Wang Y. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M. J Med Virol 2009, 81(6):1052-1061.
45. Herremans M, Bakker J, Duizer H, Vennema H, Koopmans PG. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007, 14(5):562-568.
46. Clemens SA, da Fonseca JC, Azevedo T, Cavalcanti A, Silveira TR, Castilho MC, Clemens R. Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil. Rev Soc Bras Med Trop 2000, 33(1):1-10.
47. Pinho JR, Sumita LM, Moreira RC, de Souza VA, Saraceni CP, Oba IT, Carvalho MC, Pannuti CS. Duality of patterns in hepatitis A epidemiology: a study involving two socioeconomically distinct populations in Campinas, São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo 1998, 40(2):105-106.
48. Focaccia R, da Conceic¸ão OJ, Sette H, Sabino E, Bassit L, Nitrini DR, Lomar AV, Lorenc¸o R, Vieira De Souza F, Kiffer CR, Santos EB, Gonzales MP, Sa´ez-Alque´zar A, Riscal JR, Fischer D. Estimated prevalence of viral hepatitis in the general population of the municipality of São Paulo, measured by a serologic survey of a stratified, randomized and residence-based population. Braz J Infect Dis 1998, 2(6):269-284.
49. Murhekar MV, Sehgal SC, Murhekar KM, Padbhidri SP, Chitambar SD, Arankalle VA. Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10-year period 1989-99. J Viral Hepatitis 2002, 9(4):315-321.
50. Seow HF, Mahomed NMB, Mak JW, Riddell MA, Li F, Anderson DA. Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia. J Med Virol 1999, 59:164-168.
51. Li RC, Ge SX, Li YP, Zheng YJ, Nong Y, Guo QS, Zhang J, Ng MH, Xia NS. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006, 12(11):1682-1688.
52. Vivek R, Chandy GM, Brown DW, Kang G. Seroprevalence of IgG antibodies to hepatitis E in urban and rural southern India. Trans R Soc Trop Med Hyg 2010, 104(4):307-308.
53. dos Santos DR, Vitral CL, de Paula VS, Marchevsky RS, Lopes JF, Gaspar AM, Saddi TM, Ju´nior NC, Guimarães FR, Ju´nior JG, Ximenes LL, Souto FJ, Pinto MA. Serological and molecular evidence of hepatitis E virus in swine in Brazil. Vet J 2009, 182(3):474-480.
54. Passos AM, Heringer TP, Medina-Pestana JO, Ferraz ML, Granato CF. First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil. J Med Virol 2013, 85(4):615-619.
55. de Souza AJ, Gomes-Gouveˆa MS, Soares MC, Pinho JR, Malheiros AP, Carneiro LA, dos Santos DR, Pereira WL. HEV infection in swine from Eastern Brazilian Amazon: evidence of co-infection by different subtypes. Comp Immunol Microbiol Infect Dis 2012, 35(5):477-485.
56. Dell'Amico MC, Cavallo A, Gonzales JL, Bonelli SI, Valda Y, Pieri A, Segund H, Ibañez R, Mantella A, Bartalesi F, Tolari F, Bartoloni A. Hepatitis E virus genotype 3 in humans and Swine, Bolivia. Emerg Infect Dis 2011, 17(8):1488-1490.
57. Garci´a CG, Sa´nchez D, Villalba MC, Pujol FH, de Los Angeles Rodri´guez Lay L, Pinto B, Chaco´n EP, Guzma´n MG. Molecular characterization of hepatitis E virus in patients with acute hepatitis in Venezuela. J Med Virol 2012, 84(7):1025-1029.
58. Mirazo S, Mainardi V, Ramos N, Gerona S, Rocca A, Arbiza J. Indigenous hepatitis E virus genotype 1 infection, Uruguay. Emerg Infect Dis 2014, 20(1):171-173.
59. de la Caridad Montalvo Villalba M, Owot JC, Benedito EC, Corredor MB, Flaquet PP, Frometa SS, Wong MS, Rodri´guez Lay Lde L. Hepatitis E virus genotype 3 in humans and swine, Cuba. Infect Genet Evol 2013, 14:335-339.
60. Atabek ME, Fy´ndy´k D, Gulyuz A, Erkul I. Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey. Health Policy 2004, 67(3):265-269.
61. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, Naghoosi H, Karayiannis P, Zali MR. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg 2012, 106(9):528-531.
62. Bawazir AA, Hart CA, Sallam TA, Parry CM, Beeching NJ, Cuevas LE. Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans R Soc Trop Med Hyg 2010, 104(12):801-805.
63. Bartoloni A, Bartalesi F, Roselli M, Mantella A, Arce CC, Paradisi F, Hall AJ. Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 1999, 4(9):596-601.